Clinical research - Press Releases

Date	Title	Company
15-Nov-2019	Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector	Kayentis
15-Nov-2019	Nordic Nanovector to participate in four upcoming investor conferences	Nordic Nanovector ASA
15-Nov-2019	Clinerion partners with Semedy to incorporate Semedy’s Clinical Knowledge Management System technology into Clinerion’s Patient Network Explorer.	Clinerion Ltd.
14-Nov-2019	Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration	Signant Health
14-Nov-2019	South African start-up named Africa Challenge winner for its mission to eradicate malaria	ERADA Technology Alliance Ltd
14-Nov-2019	APPOINTMENT OF JOINT BROKER	ValiRx
14-Nov-2019	Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai	Helsinn Group
14-Nov-2019	Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine	Bavarian Nordic A/S
13-Nov-2019	Autolus Therapeutics and Noile-Immune Announce Licensing Agreement	Autolus Therapeutics plc
13-Nov-2019	XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1⍺ Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)	XBiotech Inc
13-Nov-2019	UNKNOWN VIRUS DISCOVERED IN HUMAN BODY	University of Health Sciences
13-Nov-2019	NICE RECOMMENDS ELMIRON® FOR THE TREATMENT OF BLADDER PAIN SYNDROME	Consilient Health
13-Nov-2019	HEALTHY. IO CONDUCTS FIRST LARGE SCALE POPULATION SCREENING FOR CHRONIC KIDNEY DISEASE THROUGH SMARTPHONE-BASED HEALTH TECHNOLOGY	Healthy.io
12-Nov-2019	DATA SHOWING POTENTIAL FOR MACHINE LEARNING TO ADVANCE UNDERSTANDING OF NONALCOHOLIC STEATOHEPATITIS (NASH) PRESENTED AT THE LIVER MEETING® 2019	Gilead Sciences
12-Nov-2019	GILEAD ANNOUNCES NEW DATA FROM VIRAL HEPATITIS RESEARCH PROGRAMMES AT THE LIVER MEETING® 2019	Gilead Sciences
12-Nov-2019	Key Reasons to attend SMi’s 3D Cell Culture Conference 2020	SMi Group
12-Nov-2019	HERMES PHARMA Achieves Top Rating for Sustainability Performance from EcoVadis	HERMES PHARMA
12-Nov-2019	Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia	Minoryx Therapeutics
12-Nov-2019	Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium (SMC) for the treatment of patients with the most common form of advanced breast cancer	Novartis
12-Nov-2019	New Celltrion data presented at ACR for subcutaneous formulation of CT-P13 (biosimilar infliximab) in RA	Celltrion Healthcare